STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 38, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-05-14
DOI
10.1186/s13046-019-1206-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interaction of EZH2 and P65 is involved in the arsenic trioxide-induced anti-angiogenesis in human triple-negative breast cancer cells
- (2019) Fei Jiang et al. CELL BIOLOGY AND TOXICOLOGY
- Anticancer effect of nor-wogonin (5, 7, 8-trihydroxyflavone) on human triple-negative breast cancer cells via downregulation of TAK1, NF-κB, and STAT3
- (2019) Amer Ali Abd El-Hafeez et al. Pharmacological Reports
- Triple Negative Breast Cancer Profile, from Gene to microRNA, in Relation to Ethnicity
- (2019) Ishita Gupta et al. Cancers
- Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells
- (2019) Damiano Cosimo Rigiracciolo et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Breast Cancer Treatment
- (2019) Adrienne G. Waks et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Bazedoxifene is a novel IL-6/GP130 inhibitor for treating triple-negative breast cancer
- (2019) Jilai Tian et al. BREAST CANCER RESEARCH AND TREATMENT
- Investigation of B,C-ring truncated deguelin derivatives as heat shock protein 90 (HSP90) inhibitors for use as anti-breast cancer agents
- (2019) Ho Shin Kim et al. BIOORGANIC & MEDICINAL CHEMISTRY
- The oral Janus kinase/spleen tyrosine kinase inhibitor ASN 002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate‐to‐severe atopic dermatitis: results from a randomized double‐blind placebo‐controlled study
- (2019) R. Bissonnette et al. BRITISH JOURNAL OF DERMATOLOGY
- C-terminal HSP90 inhibitor L80 elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition
- (2019) Tae-Min Cho et al. CANCER LETTERS
- Combined bazedoxifene and paclitaxel treatments inhibit cell viability, cell migration, colony formation, and tumor growth and induce apoptosis in breast cancer
- (2019) Shengling Fu et al. CANCER LETTERS
- Isoharringtonine inhibits breast cancer stem-like properties and STAT3 signaling
- (2018) Wei Chen et al. BIOMEDICINE & PHARMACOTHERAPY
- Syntenin1/MDA-9 (SDCBP) induces immune evasion in triple-negative breast cancer by upregulating PD-L1
- (2018) Jing Liu et al. BREAST CANCER RESEARCH AND TREATMENT
- The role of STAT3 in leading the crosstalk between human cancers and the immune system
- (2018) Yu Wang et al. CANCER LETTERS
- Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing
- (2018) Charissa Kim et al. CELL
- STAT3, stem cells, cancer stem cells and p63
- (2018) Michaela Galoczova et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- JAK2 and PD-L1 Amplification Enhance the Dynamic Expression of PD-L1 in Triple-negative Breast Cancer
- (2018) Meixuan Chen et al. Clinical Breast Cancer
- Update on the Treatment of Early-Stage Triple-Negative Breast Cancer
- (2018) Priyanka Sharma CURRENT TREATMENT OPTIONS IN ONCOLOGY
- STAT3 as a promising chemoresistance biomarker associated with the CD44 +/high /CD24 -/low /ALDH + BCSCs-like subset of the triple-negative breast cancer (TNBC) cell line
- (2018) Milene Pereira Moreira et al. EXPERIMENTAL CELL RESEARCH
- Dual inhibition of STAT1 and STAT3 activation downregulates expression of PD-L1 in human breast cancer cells
- (2018) Varun Sasidharan Nair et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- STAT3: a multifaceted oncoprotein
- (2018) Aleks C. Guanizo et al. GROWTH FACTORS
- Flubendazole elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition
- (2018) Eunhye Oh et al. INTERNATIONAL JOURNAL OF CANCER
- Interleukin-6 contributes to chemoresistance in MDA-MB-231 cells via targeting HIF-1α
- (2018) Ke Wang et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Bt354 as a new STAT3 signaling pathway inhibitor against triple negative breast cancer
- (2018) Yue Chen et al. JOURNAL OF DRUG TARGETING
- STAT3 Cyclic Decoy Demonstrates Robust Antitumor Effects in Non-Small Cell Lung Cancer
- (2018) Christian Njatcha et al. MOLECULAR CANCER THERAPEUTICS
- Targeting the IL-6/JAK/STAT3 signalling axis in cancer
- (2018) Daniel E. Johnson et al. Nature Reviews Clinical Oncology
- Activation of STAT3 and Bcl-2 and reduction of reactive oxygen species (ROS) promote radioresistance in breast cancer and overcome of radioresistance with niclosamide
- (2018) Lu Lu et al. ONCOGENE
- Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer
- (2018) Sherona R. Sirkisoon et al. ONCOGENE
- SRT1720, a potential sensitizer for radiotherapy and cytotoxicity effects of NVB-BEZ235 in metastatic breast cancer cells
- (2018) Daryoush Fatehi et al. PATHOLOGY RESEARCH AND PRACTICE
- Lysine methyltransferase SMYD2 promotes triple negative breast cancer progression
- (2018) Linda Xiaoyan Li et al. Cell Death & Disease
- Phase I Dose-Finding Study of OPB-111077, a Novel STAT3 Inhibitor, in Patients with Advanced Hepatocellular Carcinoma
- (2018) Changhoon Yoo et al. Cancer Research and Treatment
- HN1L Promotes Triple-Negative Breast Cancer Stem Cells through LEPR-STAT3 Pathway
- (2018) Yi Liu et al. Stem Cell Reports
- The STAT3 Target Gene TNFRSF1A Modulates the NF-κB Pathway in Breast Cancer Cells
- (2018) Susana P. Egusquiaguirre et al. NEOPLASIA
- Constitutive Activation of STAT3 in Myeloma Cells Cultured in a Three-Dimensional, Reconstructed Bone Marrow Model
- (2018) Yung-Hsing Huang et al. Cancers
- Interleukin-22 promotes triple negative breast cancer cells migration and paclitaxel resistance through JAK-STAT3/MAPKs/AKT signaling pathways
- (2018) Shuqian Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Emerging PARP inhibitors for treating breast cancer
- (2018) Marie Robert et al. EXPERT OPINION ON EMERGING DRUGS
- Thioridazine inhibits self-renewal in breast cancer cells via DRD2-dependent STAT3 inhibition, but induces a G1 arrest independent of DRD2
- (2018) Matthew Tegowski et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Bioassay-guided isolation of cantharidin from blister beetles and its anticancer activity through inhibition of epidermal growth factor receptor-mediated STAT3 and Akt pathways
- (2018) Jaemoo Chun et al. Journal of Natural Medicines
- Sesquiterpene lactones-enriched fraction of Inula helenium L. induces apoptosis through inhibition of signal transducers and activators of transcription 3 signaling pathway in MDA-MB-231 breast cancer cells
- (2018) Jaemoo Chun et al. PHYTOTHERAPY RESEARCH
- The molecular details of cytokine signalling via the JAK/STAT pathway
- (2018) Rhiannon Morris et al. PROTEIN SCIENCE
- Schisandrin B exhibits potent anticancer activity in triple negative breast cancer by inhibiting STAT3
- (2018) Xuanxuan Dai et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Loss of Wwox drives metastasis in triple-negative breast cancer by JAK2/STAT3 axis
- (2018) Renxu Chang et al. Nature Communications
- “Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway
- (2018) Emira Bousoik et al. Frontiers in Oncology
- GGNBP2 suppresses triple-negative breast cancer aggressiveness through inhibition of IL-6/STAT3 signaling activation
- (2018) Jingjing Liu et al. BREAST CANCER RESEARCH AND TREATMENT
- Hypoxia-induced tRNA-derived fragments, novel regulatory factor for doxorubicin resistance in triple-negative breast cancer
- (2018) Yangyang Cui et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Osthole inhibits triple negative breast cancer cells by suppressing STAT3
- (2018) Xuanxuan Dai et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- A new synthetic derivative of cryptotanshinone KYZ3 as STAT3 inhibitor for triple-negative breast cancer therapy
- (2018) Wenda Zhang et al. Cell Death & Disease
- Ganoderma lucidum extract (GLE) impairs breast cancer stem cells by targeting the STAT3 pathway
- (2018) Tiffany J. Rios-Fuller et al. Oncotarget
- Kinome-Wide siRNA Screening Identifies Src-Enhanced Resistance of Chemotherapeutic Drugs in Triple-Negative Breast Cancer Cells
- (2018) Yen-Dun Tony Tzeng et al. Frontiers in Pharmacology
- The clinical promise of immunotherapy in triple-negative breast cancer
- (2018) Praveen Vikas et al. Cancer Management and Research
- STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial
- (2018) Matthew J. Reilley et al. Journal for ImmunoTherapy of Cancer
- Modulation of Hypoxia-Induced Chemoresistance to Polymeric Micellar Cisplatin: The Effect of Ligand Modification of Micellar Carrier Versus Inhibition of the Mediators of Drug Resistance
- (2018) Hoda Soleymani Abyaneh et al. Pharmaceutics
- STAT3 activation by leptin receptor is essential for TNBC stem cell maintenance
- (2017) Praveena S Thiagarajan et al. ENDOCRINE-RELATED CANCER
- Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer
- (2017) Alan P. Venook et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sequential combination of docetaxel with a SHP-1 agonist enhanced suppression of p-STAT3 signaling and apoptosis in triple negative breast cancer cells
- (2017) Chun-Yu Liu et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- A Second-Generation Proteasome Inhibitor and Doxorubicin Modulates IL-6, pSTAT-3 and NF-kB Activity in MDA-MB-231 Breast Cancer Cells
- (2017) Dinesh Vyas et al. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
- Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways
- (2017) Sherif Abdelaziz Ibrahim et al. Molecular Cancer
- Sorafenib analogue SC-60 induces apoptosis through the SHP-1/STAT3 pathway and enhances docetaxel cytotoxicity in triple-negative breast cancer cells
- (2017) Chun-Yu Liu et al. Molecular Oncology
- Precise discovery of a STAT3 inhibitor from Eupatorium lindleyanum and evaluation of its activity of anti-triple-negative breast cancer
- (2017) Bo Yang et al. NATURAL PRODUCT RESEARCH
- Silibinin downregulates MMP2 expression via Jak2/STAT3 pathway and inhibits the migration and invasive potential in MDA-MB-231 cells
- (2017) Hyo Joo Byun et al. ONCOLOGY REPORTS
- The JAK/STAT3 axis: A comprehensive drug target for solid malignancies
- (2017) Jennifer Huynh et al. SEMINARS IN CANCER BIOLOGY
- Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells
- (2017) Sin-Ting Wang et al. Cell Death & Disease
- Binding of galectin-1 to integrin β1 potentiates drug resistance by promoting survivin expression in breast cancer cells
- (2017) KeeSoo Nam et al. Oncotarget
- STAT3/NF-κB-Regulated Lentiviral TK/GCV Suicide Gene Therapy for Cisplatin-Resistant Triple-Negative Breast Cancer
- (2017) Wei-Ying Kuo et al. Theranostics
- STAT3 but Not HIF-1α Is Important in Mediating Hypoxia-Induced Chemoresistance in MDA-MB-231, a Triple Negative Breast Cancer Cell Line
- (2017) Hoda Soleymani Abyaneh et al. Cancers
- The IL-6/STAT3 Signaling Pathway Is an Early Target of Manuka Honey-Induced Suppression of Human Breast Cancer Cells
- (2017) Priyanka Aryappalli et al. Frontiers in Oncology
- Strategies and Approaches of Targeting STAT3 for Cancer Treatment
- (2016) Steffanie L. Furtek et al. ACS Chemical Biology
- MicroRNA-544 down-regulates both Bcl6 and Stat3 to inhibit tumor growth of human triple negative breast cancer
- (2016) Zhengzhi Zhu et al. BIOLOGICAL CHEMISTRY
- Mitochondrial Stat3, the Need for Design Thinking
- (2016) Rui Yang et al. International Journal of Biological Sciences
- Arctigenin inhibits STAT3 and exhibits anticancer potential in human triple-negative breast cancer therapy
- (2016) Tingting Feng et al. Oncotarget
- Disrupting VEGF-A paracrine and autocrine loops by targeting SHP-1 suppresses triple negative breast cancer metastasis
- (2016) Jung-Chen Su et al. Scientific Reports
- Rhus coriaria suppresses angiogenesis, metastasis and tumor growth of breast cancer through inhibition of STAT3, NFκB and nitric oxide pathways
- (2016) Hussain El Hasasna et al. Scientific Reports
- Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignancies
- (2015) A. L. Wong et al. ANNALS OF ONCOLOGY
- Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells
- (2015) Jaemoo Chun et al. CANCER LETTERS
- Critical Roles of STAT3 in β-Adrenergic Functions in the HeartCLINICAL PERSPECTIVE
- (2015) Wenjun Zhang et al. CIRCULATION
- The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition
- (2015) Christoph Garbers et al. CURRENT OPINION IN IMMUNOLOGY
- Induction of miRNA-181a by genotoxic treatments promotes chemotherapeutic resistance and metastasis in breast cancer
- (2015) J Niu et al. ONCOGENE
- Isolinderalactone enhances the inhibition of SOCS3 on STAT3 activity by decreasing miR-30c in breast cancer
- (2015) MENG-CHI YEN et al. ONCOLOGY REPORTS
- AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer
- (2015) David Hong et al. Science Translational Medicine
- A key role for PTP1B in dendritic cell maturation, migration, and T cell activation
- (2015) Cristina Martin-Granados et al. Journal of Molecular Cell Biology
- Disruption of STAT3-DNMT1 interaction by SH-I-14 induces re-expression of tumor suppressor genes and inhibits growth of triple-negative breast tumor
- (2015) Hyo Jin Kang et al. Oncotarget
- Phase I Study of OPB-31121, an Oral STAT3 Inhibitor, in Patients with Advanced Solid Tumors
- (2015) Do-Youn Oh et al. Cancer Research and Treatment
- Salinomycin Promotes Anoikis and Decreases the CD44+/CD24- Stem-Like Population via Inhibition of STAT3 Activation in MDA-MB-231 Cells
- (2015) Hyunsook An et al. PLoS One
- Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells
- (2014) Chun-Yu Liu et al. BREAST CANCER RESEARCH AND TREATMENT
- STAT3-Mediated Autophagy Dependence Identifies Subtypes of Breast Cancer Where Autophagy Inhibition Can Be Efficacious
- (2014) P. Maycotte et al. CANCER RESEARCH
- Novel Carbazole Inhibits Phospho-STAT3 through Induction of Protein–Tyrosine Phosphatase PTPN6
- (2014) Shujie Hou et al. JOURNAL OF MEDICINAL CHEMISTRY
- Peripheral Nerve Regeneration and NGF-Dependent Neurite Outgrowth of Adult Sensory Neurons Converge on STAT3 Phosphorylation Downstream of Neuropoietic Cytokine Receptor gp130
- (2014) S. Quarta et al. JOURNAL OF NEUROSCIENCE
- XPO1 (CRM1) Inhibition Represses STAT3 Activation to Drive a Survivin-Dependent Oncogenic Switch in Triple-Negative Breast Cancer
- (2014) Y. Cheng et al. MOLECULAR CANCER THERAPEUTICS
- VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2
- (2014) D Zhao et al. ONCOGENE
- Induction of fibronectin in response to epidermal growth factor is suppressed by silibinin through the inhibition of STAT3 in triple negative breast cancer cells
- (2014) SANGMIN KIM et al. ONCOLOGY REPORTS
- Syndecan-1 (CD138) Modulates Triple-Negative Breast Cancer Stem Cell Properties via Regulation of LRP-6 and IL-6-Mediated STAT3 Signaling
- (2014) Sherif A. Ibrahim et al. PLoS One
- Breast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasis
- (2014) Esak Lee et al. Nature Communications
- Syndecan-1 Overexpression Is Associated With Nonluminal Subtypes and Poor Prognosis in Advanced Breast Cancer
- (2013) Thuy L. Nguyen et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Regulation of STAT signaling by acetylation
- (2013) Shougang Zhuang CELLULAR SIGNALLING
- Down-regulation of GRIM-19 is associated with STAT3 overexpression in breast carcinomas
- (2013) Tao Zhou et al. HUMAN PATHOLOGY
- Mitochondrial Localized Stat3 Promotes Breast Cancer Growth via Phosphorylation of Serine 727
- (2013) Qifang Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A randomized, placebo-controlled study of the pharmacokinetics, pharmacodynamics, and tolerability of the oral JAK2 inhibitor fedratinib (SAR302503) in healthy volunteers
- (2013) Meng Zhang et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Deguelin Action Involves c-Met and EGFR Signaling Pathways in Triple Negative Breast Cancer Cells
- (2013) Rajeshwari Mehta et al. PLoS One
- Role of STAT3 in Cancer Metastasis and Translational Advances
- (2013) Mohammad Zahid Kamran et al. Biomed Research International
- Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers
- (2012) Xin-Sheng Deng et al. CELL CYCLE
- Phospho-Ser727 of STAT3 regulates STAT3 activity by enhancing dephosphorylation of phospho-Tyr705 largely through TC45
- (2012) Ryohei Wakahara et al. GENES TO CELLS
- TCPTP Regulates SFK and STAT3 Signaling and Is Lost in Triple-Negative Breast Cancers
- (2012) Benjamin J. Shields et al. MOLECULAR AND CELLULAR BIOLOGY
- Methylsulfonylmethane Suppresses Breast Cancer Growth by Down-Regulating STAT3 and STAT5b Pathways
- (2012) Eun Joung Lim et al. PLoS One
- The Ubiquitin Ligase TRAF6 Negatively Regulates the JAK-STAT Signaling Pathway by Binding to STAT3 and Mediating Its Ubiquitination
- (2012) Juncheng Wei et al. PLoS One
- Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation
- (2012) H. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Stat3: linking inflammation to epithelial cancer - more than a "gut" feeling?
- (2012) Andrew Jarnicki et al. Cell Division
- Oral administration of penta-O-galloyl- -D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition
- (2011) H.-J. Lee et al. CARCINOGENESIS
- Leptin deficiency suppresses MMTV-Wnt-1 mammary tumor growth in obese mice and abrogates tumor initiating cell survival
- (2011) Q. Zheng et al. ENDOCRINE-RELATED CANCER
- STAT3 and its activators in intestinal defense and mucosal homeostasis
- (2010) Petr Hruz et al. CURRENT OPINION IN GASTROENTEROLOGY
- Protein Tyrosine Phosphatases, TC-PTP, SHP1, and SHP2, Cooperate in Rapid Dephosphorylation of Stat3 in Keratinocytes Following UVB Irradiation
- (2010) Dae Joon Kim et al. PLoS One
- The enigma of the role of Protein inhibitor of Activated STAT3 (PIAS3) in the immune response
- (2010) Zohar Yagil et al. TRENDS IN IMMUNOLOGY
- The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors
- (2009) Michael Hedvat et al. CANCER CELL
- Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in Tumors
- (2009) Heehyoung Lee et al. CANCER CELL
- Function of Mitochondrial Stat3 in Cellular Respiration
- (2009) J. Wegrzyn et al. SCIENCE
- Cryptotanshinone Inhibits Constitutive Signal Transducer and Activator of Transcription 3 Function through Blocking the Dimerization in DU145 Prostate Cancer Cells
- (2008) D.-S. Shin et al. CANCER RESEARCH
- WP1066, a Novel JAK2 Inhibitor, Suppresses Proliferation and Induces Apoptosis in Erythroid Human Cells Carrying the JAK2 V617F Mutation
- (2008) S. Verstovsek et al. CLINICAL CANCER RESEARCH
- Lapatinib: A dual inhibitor of human epidermal growth factor receptor tyrosine kinases
- (2008) P MEDINA et al. CLINICAL THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search